IFNL3 (interferon lambda 3)

2009-09-01  

Identity

HGNC
LOCATION
19q13.2
LOCUSID
ALIAS
IFN-lambda-3,IFN-lambda-4,IL-28B,IL-28C,IL28B,IL28C

Other Information

Locus ID:

NCBI: 282617
MIM: 607402
HGNC: 18365
Ensembl: ENSG00000197110

Variants:

dbSNP: 282617
ClinVar: 282617
TCGA: ENSG00000197110
COSMIC: IFNL3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197110ENST00000413851Q8IZI9
ENSG00000197110ENST00000613087A0A0C4DGW8

Expression (GTEx)

0
1

Pathways

PathwaySourceExternal ID
Cytokine-cytokine receptor interactionKEGGko04060
Jak-STAT signaling pathwayKEGGko04630
Cytokine-cytokine receptor interactionKEGGhsa04060
Jak-STAT signaling pathwayKEGGhsa04630
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Signaling by InterleukinsREACTOMER-HSA-449147

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA164749390peginterferon alfa-2aChemicalClinicalAnnotation, GuidelineAnnotation, Literature, MultilinkAnnotation, VariantAnnotationassociatedPD19684573, 19749757, 19749758, 20060832, 20399780, 20434452, 20578254, 20621700, 20648473, 20728570, 20804372, 20964522, 21068134, 21112657, 21112660, 21145807, 21246582, 21254157, 21346780, 21360545, 21374656, 21384511, 21390311, 21447862, 21466653, 21503910, 21537116, 21572301, 21606533, 21726252, 21739446, 21745312, 21907615, 21911885, 21951981, 21987611, 21993426, 22301466, 22328925, 22345656, 22438096, 22863269, 23142377, 23281610, 23321318, 23383658, 23490377, 23730840, 24072198, 24096968, 24102823, 24117654, 24308755, 24355007, 24362944, 24602923, 24768758, 24907224, 24929144, 25080450, 25287681, 25534433, 25769643, 25918016, 25958342, 26003758, 26032235, 26186989, 26284539, 26825765, 26902034, 27498543, 27514956, 27714501, 27833958, 28072888, 28261910, 28453395, 28703131, 28739427, 29369421, 30016335, 30450628, 31201901
PA164784024peginterferon alfa-2bChemicalClinicalAnnotation, GuidelineAnnotation, LabelAnnotation, Literature, MultilinkAnnotation, VariantAnnotationassociatedPD19684573, 19749757, 19749758, 20060832, 20399780, 20434452, 20578254, 20621700, 20648473, 20728570, 20804372, 20964522, 21068134, 21112657, 21112660, 21145807, 21246582, 21254157, 21346780, 21360545, 21374656, 21384511, 21390311, 21447862, 21466653, 21503910, 21537116, 21572301, 21606533, 21726252, 21739446, 21745312, 21907615, 21911885, 21951981, 21987611, 21993426, 22301466, 22328925, 22345656, 22438096, 22626609, 22863269, 23142377, 23281610, 23321318, 23383658, 23490377, 23730840, 24072198, 24096968, 24102823, 24117654, 24308755, 24355007, 24362944, 24602923, 24768758, 24907224, 24929144, 25080450, 25287681, 25534433, 25769643, 25918016, 25958342, 26003758, 26032235, 26186989, 26284539, 26825765, 26902034, 27498543, 27514956, 27714501, 27833958, 28072888, 28261910, 28703131, 28739427, 29369421, 30450628
PA165948902boceprevirChemicalClinicalAnnotation, LabelAnnotation, Literature, MultilinkAnnotationassociatedPD22626609, 24096968, 25836019
PA165958354telaprevirChemicalClinicalAnnotation, LabelAnnotation, Literature, MultilinkAnnotationassociatedPD20648473, 21246582, 23321318, 24096968, 24117654, 24362944
PA166122590simeprevirChemicalClinicalAnnotation, LabelAnnotationassociatedPD24602923, 24907224, 28072888
PA166122593sofosbuvirChemicalClinicalAnnotation, LabelAnnotation, VariantAnnotationassociatedPD25734178, 27357737, 28100007, 29107709, 29534310, 30431653
PA166128130deleobuvirChemicalClinicalAnnotationassociatedPD23944300
PA166128132faldaprevirChemicalClinicalAnnotationassociatedPD23944300
PA166128166ledipasvirChemicalClinicalAnnotationassociatedPD25734178, 27357737, 28100007
PA166128167daclatasvirChemicalClinicalAnnotation, LabelAnnotation, VariantAnnotationassociatedPD25080450, 30431653
PA166131629sustained virological response (svr)DiseaseVariantAnnotationassociatedPD30431653
PA166155435rs8099917VariantLabelAnnotationassociated
PA166155437rs8103142VariantLabelAnnotationassociated
PA166155468rs12979860VariantLabelAnnotationassociated
PA166160002dasabuvir / ombitasvir / paritaprevir / ritonavirChemicalLabelAnnotationassociated
PA166163408ombitasvir / paritaprevir / ritonavirChemicalLabelAnnotationassociated
PA166163411dasabuvirChemicalLabelAnnotationassociated
PA166163415velpatasvirChemicalClinicalAnnotationassociatedPD29107709
PA166163416sofosbuvir / velpatasvirChemicalLabelAnnotationassociated
PA166163427ledipasvir / sofosbuvirChemicalLabelAnnotationassociated
PA166163438elbasvir / grazoprevirChemicalLabelAnnotationassociated
PA166171182voxilaprevirChemicalClinicalAnnotationassociatedPD29107709
PA166177517sofosbuvir / velpatasvir / voxilaprevirChemicalLabelAnnotationassociated
PA444445Hepatitis CDiseaseClinicalAnnotation, VariantAnnotationassociatedPD19684573, 19749757, 20399780, 20578254, 20621700, 20728570, 20804372, 20964522, 21068134, 21112657, 21145807, 21374656, 21447862, 21466653, 21537116, 21572301, 21606533, 21726252, 21907615, 21911885, 21951981, 21993426, 22328925, 22345656, 22438096, 22863269, 23142377, 23281610, 23321318, 23383658, 23490377, 24072198, 24102823, 24117654, 24308755, 24768758, 25287681, 25918016, 25958342, 26032235, 26186989, 26284539, 26902034, 27498543, 27514956, 27714501, 27833958, 28261910, 28703131, 28739427, 30450628
PA445016Myeloproliferative DisordersDiseaseClinicalAnnotationassociatedPD29369421
PA445506RecurrenceDiseaseClinicalAnnotationassociatedPD28100007
PA446862Hepatitis B, ChronicDiseaseClinicalAnnotationassociatedPD28453395, 30016335, 31201901
PA446863Hepatitis C, ChronicDiseaseClinicalAnnotation, VariantAnnotationassociatedPD19749757, 19749758, 20060832, 20434452, 20648473, 21068134, 21112657, 21112660, 21145807, 21246582, 21254157, 21346780, 21360545, 21374656, 21384511, 21390311, 21466653, 21503910, 21739446, 21745312, 21907615, 21911885, 21987611, 22301466, 22328925, 22345656, 22438096, 22626609, 22863269, 23142377, 23281610, 23321318, 23730840, 23944300, 24102823, 24117654, 24308755, 24355007, 24362944, 24602923, 24768758, 24907224, 24929144, 25080450, 25534433, 25734178, 25769643, 26003758, 26825765, 27357737, 28072888, 28100007, 29107709, 29534310, 30431653
PA447230HIVDiseaseClinicalAnnotationassociatedPD19749757, 22328925, 23281610, 25287681, 26186989
PA451241ribavirinChemicalClinicalAnnotation, GuidelineAnnotation, Literature, MultilinkAnnotation, VariantAnnotationassociatedPD19684573, 19749757, 19749758, 20060832, 20399780, 20434452, 20578254, 20621700, 20648473, 20728570, 20804372, 20964522, 21068134, 21112657, 21112660, 21145807, 21246582, 21254157, 21346780, 21360545, 21374656, 21384511, 21390311, 21447862, 21466653, 21503910, 21537116, 21572301, 21606533, 21726252, 21739446, 21745312, 21907615, 21911885, 21951981, 21987611, 21993426, 22301466, 22328925, 22345656, 22438096, 22626609, 22863269, 23142377, 23281610, 23321318, 23383658, 23490377, 23730840, 24072198, 24096968, 24102823, 24117654, 24308755, 24355007, 24362944, 24602923, 24768758, 24907224, 24929144, 25080450, 25287681, 25534433, 25769643, 25918016, 25958342, 26003758, 26032235, 26186989, 26284539, 26825765, 26902034, 27498543, 27514956, 27714501, 27833958, 28072888, 28261910, 28703131, 28739427, 30450628
PA451999interferonsChemicalClinicalAnnotationassociatedPD19749757, 19749758, 20060832, 20434452, 21068134, 21112657, 21112660, 21145807, 21254157, 21360545, 21374656, 21384511, 21466653, 21503910, 21739446, 21745312, 21907615, 21911885, 22301466, 22345656, 22438096, 22863269, 23142377, 23281610, 23730840, 24102823, 24308755, 24355007, 24768758, 24929144, 26003758, 26825765

References

Pubmed IDYearTitleCitations
124832102003IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.581
124691192003IL-28, IL-29 and their class II cytokine receptor IL-28R.481
234202322013Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.77
214029222011Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.55
213903112011Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.52
219315402011IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.47
212541582011Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.42
239507092013A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.40
221928852012Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.37
223144302012IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.33

Citation

Dessen P

IFNL3 (interferon lambda 3)

Atlas Genet Cytogenet Oncol Haematol. 2009-09-01

Online version: http://atlasgeneticsoncology.org/gene/51058/ifnl3